Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Diabetes

Journal Scan / Research · July 17, 2022

Sustained Reduction in Hypoglycemia With the Use of CGM in Older Adults With Type 1 Diabetes

Diabetes Technology & Therapeutics


Additional Info

Diabetes Technology & Therapeutics
Benefit of Continuous Glucose Monitoring in Reducing Hypoglycemia Is Sustained Through 12 Months of Use Among Older Adults with Type 1 Diabetes
Diabetes Technol. Ther. 2022 Jun 01;24(6)424-434, KM Miller, LG Kanapka, MR Rickels, AJ Ahmann, G Aleppo, L Ang, A Bhargava, BW Bode, A Carlson, NS Chaytor, G Gannon, R Goland, IB Hirsch, L Kiblinger, D Kruger, YC Kudva, CJ Levy, JB McGill, G O'Malley, AL Peters, LH Philipson, A Philis-Tsimikas, R Pop-Busui, M Salam, VN Shah, MJ Thompson, F Vendrame, A Verdejo, RS Weinstock, L Young, R Pratley

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading